1,7-phenanthroline has been researched along with Cardiovascular Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, SW; Dong, XL; Fan, XD; Guo, DJ; Li, CM; Qiu, TQ; Tian, XL; Wang, QH; Wong, MS; Wu, JH | 1 |
| Huang, L; Li, X; Li, Y; Tang, S; Wang, J; Wang, X; Wang, Y; Xu, H; Xu, X; Yang, H; Yang, L; Yang, S; Yu, H | 1 |
2 other study(ies) available for 1,7-phenanthroline and Cardiovascular Diseases
| Article | Year |
|---|---|
Aqueous extract of danshen (Salvia miltiorrhiza Bunge) protects ovariectomized rats fed with high-fat diet from endothelial dysfunction.
Topics: Animals; Aorta, Thoracic; Cardiovascular Diseases; Diet, High-Fat; Drugs, Chinese Herbal; Endothelium, Vascular; Fatty Liver; Female; Gene Expression Regulation; Intercellular Adhesion Molecule-1; Lipids; Nitric Oxide; Nitric Oxide Synthase Type III; Ovariectomy; Phenanthrolines; Rats; Rats, Sprague-Dawley; Salvia miltiorrhiza; Tumor Necrosis Factor-alpha; Vascular Cell Adhesion Molecule-1; Vasodilation; Weight Gain | 2013 |
A system-level investigation into the mechanisms of Chinese Traditional Medicine: Compound Danshen Formula for cardiovascular disease treatment.
Topics: Administration, Oral; Biological Availability; Cardiovascular Diseases; Computer Simulation; Databases, Factual; Drugs, Chinese Herbal; Humans; Medicine, Chinese Traditional; Metabolic Networks and Pathways; Models, Biological; Molecular Docking Simulation; Molecular Dynamics Simulation; Pharmacogenetics; Phenanthrolines; Salvia miltiorrhiza; Signal Transduction; Systems Biology; Thermodynamics | 2012 |